pharmaphorum4 年
GSK steals march on AZ as FDA approves Trelegy in asthma
Trelegy combines fluticasone furoate, an inhaled corticosteroid, umeclidinium, a long-acting muscarinic antagonist; and vilanterol, a long-acting beta2-adrenergic agonist, delivered in GSK’s ...